How Talking Medicines Is Positioned to Lead 

For more than a decade, healthcare marketers have lived in an SEO world – a world built on keywords, search algorithms, and battling for visibility on Google. But that era is ending. We’re now entering the age of GEO: Generative Engine Optimisation, where AI assistants replace traditional search and become the new gateway to information. 

This shift is seismic.
And for Pharma and MedComms, it will force a complete rethink of how scientific messages are discovered, understood, and verified. 

What is GEO, and why does it change everything? 

GEO is the practice of optimising content so it is accurately represented inside generative AI systems like ChatGPT, Claude, and Med-AI platforms. In this new model: 

• Users don’t search; 

• Users ask. 

• AI doesn’t retrieve links; 

• AI generates answers. 

This means influence shifts from “what ranks” to what the model knows – and whether it has the right, trusted data to generate safe, compliant guidance. 

For healthcare, where accuracy is life-critical, this takes the challenge to an entirely new level. 

The Problem: General AI Isn’t Safe for Healthcare Messaging 

General-purpose LLMs perform well in open domains, but in healthcare they expose three unavoidable risks: 

1. They hallucinate
   Without deep clinical context, they fill gaps with unsafe or inaccurate assumptions. 

1. They distort messaging
   They blend conflicting public data, mixing patient chatter, marketing language, news, and social noise. 

1. They cannot measure impact
   They can generate text, but cannot evaluate whether Physicians understand it, trust it, or act on it. 

GEO in healthcare diverges sharply from GEO in consumer markets: It requires validated, domain-trained, regulatory-safe data. 

Why Talking Medicines Is Perfectly Positioned for GEO 

Long before GEO was a term, Talking Medicines built the pillars that GEO now demands: 

• A proprietary way to curate real-life HCP voices 

We work with our Customers to curate first-party real-life data from HCPs – not generic web text. 

Talking Medicines has a unique advantage:
Our AI models are provided the data which messages are evaluated against. 

• Life-sciences-trained models built specifically for drugs, diseases, and behaviour 

Our domain-specific models understand nuance: 

• medical terminology 

• therapeutic areas 

• scientific messages 

• behavioural signals 

• prescribing drivers 

This is the foundation GEO systems need – and general LLMs cannot replicate without specialised training. 

The Message Resonance Score™: the missing evidence layer in GEO 

In the GEO era, Pharma and agencies will need one critical new capability: 

✔ Can we predict what messages will resonate?
✔ Can we measure the impact once they are in the market?
✔ Can we connect message → behaviour → causality? 

Talking Medicines uniquely delivers this through the Message Resonance Score™ – an evidence-based, data-driven measure of message impact. 

In a GEO world, this becomes essential:
AI will generate more messages: Talking Medicines can tell you which ones matter. 

The Future: Pharma Needs to Shape AI, Not Chase It 

GEO will accelerate a major transformation in healthcare marketing: 

• Physicians will increasingly ask AI for guidance 

• Brand messages will be blended into generative responses 

• Regulatory standards will tighten around AI-driven information 

• Pharma will need provable, auditable evidence of message safety and impact 

The companies that win in this environment will be those who can control their narrative inside AI assistants – safely, accurately, and with measurable influence. 

Talking Medicines’ Role in This New Landscape 

Talking Medicines becomes: 

The trusted data layer 

Working with customers to get to the health-trained datasets that GEO systems depend on. 

The predictive intelligence layer 

Anticipating message resonance before campaigns launch. 

The measurement layer 

Quantifying how messages shift HCP understanding and behaviour. 

Together, these capabilities position Talking Medicines as the Category Creator for Predictive Intelligence in Pharma Marketing – and now, as a core enabler of GEO in healthcare. 

Conclusion: GEO isn’t a threat – it’s the catalyst for healthcare to finally modernise messaging 

For the first time, Pharma and MedComms can close the loop between: 

Message → AI interpretation → Physician behaviour → ROI 

Talking Medicines sits at the centre of this transformation, providing the expertise, models, and evidence needed to ensure GEO becomes a competitive advantage rather than a compliance risk. 

SEO optimised the web.
GEO will optimise intelligence.
And in healthcare, intelligence must be domain-trained, measurable, and trusted – exactly what Talking Medicines was built to deliver.